We aimed to compare duration of uterine artery embolization, radiation exposure, safety and quality of life associated with the procedure in patients undergoing uterine artery embolization using transradial and transfemoral access. METHODSThis randomized controlled trial was conducted from February 2013 to March 2017 in three hospitals. Transradial access was used in 78 patients and transfemoral access in 75 patients. Clinical characteristics of the patients were comparable between the two groups. Patients were evaluated for the success and duration of the procedure, radiation exposure, major and minor complications. Quality of life associated with the procedure was assessed among patients with uterine fibroids. RESULTSEmbolization procedures were successfully performed in all patients in both groups. The duration of uterine artery embolization (32.27±7.99 vs. 39.24±9.72 minutes, p < 0.001), uterine artery catheterization time (12.36±5.73 vs. 19.08±6.06 minutes, p < 0.001) and radiation exposure (0.28±0.14 vs. 0.5±0.21 mZv, p < 0.001) were significantly lower in the transradial access group. The rate of major (0% vs. 2.7%, p = 0.37) and minor (11.53% vs. 17.3%, p = 0.42) complications was comparable between the two groups. Transradial access was associated with a statistically significant improvement in the quality of life associated with the procedure among patients with uterine fibroids. CONCLUSIONTransradial access in uterine artery embolization has the same efficacy and safety compared to transfemoral access. This access reduces radiation exposure and duration of the procedure.
Treatment of benign prostatic hyperplasia is an important and challenging problem of modern medicine. One of the most modern methods of the treatment of this disease is prostatic artery embolization. This procedure is most often done through transfemoral approach. Transradial vascular access has many advantages over the transfemoral access. Our study presents a comparative analysis of the use of transradial and transfemoral approach in this type of interventions. Transradial access was used in 13 patients, and transfemoral access - in 12 patients. The success of the procedure was 100% in both groups. The total duration of the procedure, the time needed for catheterization of internal iliac and prostatic arteries and the radiation exposure were significantly lower in the transradial approach group. There were no significant differences in the incidence of complications between two groups. The use of the transradial access was associated with a significant reduction of the frequency and severity of the discomfort associated with the procedure. Transradial approach has numerous advantages over the transfemoral approach and may have great clinical significance.
Aim: The aim of the study was evaluation of the efficacy of prophylactic use of a single dose of a beta-lactamase antibiotic and aminoglycosideadministered locally and/or systemically during cardiac pacemaker insertion procedures. Materials and methods: The analysis was carried out over a period from 30.04.1992 to 30.06.2000. A total of 2215 procedures were carried out on 1072 women and 1143 men aged between 18 and 101 years (mean age 72,5 years). The following pacemakers were implanted: AAI/AAIR-122. WINVIR-1440, VDDNDDR-50, DDD/DDDR-293, BiA-4, BW-2, pacemakers were replaced in 264 patients (pts). Each procedure was preceded by intravenous administration of an antibiotic: beta-lactamasecephalospodn and aminoglycoside. Closure of the cavity was preceded by locally "washing it out" with the cephalosporin previously administered intravenously. Further administration of the antibiotic depended on the presence of risk of infection factors. These were assumed to be: temporary transvenous cardiac pacing, extended duration of procedure (50-60 min.), immunological disorders, diabetes, infectious foci not eliminated prior to the operation. The "standard" procedure -a single dose of antibiotic prior to the surgical procedure and topical administration -was performed in 1649 pts (74%). This method made it possible to avoid complications in the form of infection, during the 9-year observation pedod of the group of pts without risk factors, in 100% of cases. In 6 out of 566 pts (1,1%) with at least one risk of infection factor, inflammation developed above the course of the electrode. In all pts this complication was controlled by conservative therapy without necessitating removal of the system. Conclusions: The prophylactic antibiotic therapy scheme (single intravenous dose combined with local lavage of the pacemaker cavity) used in permanent cardiac pacing procedures enabled elimination of infectious complications in the group of pts without risk factors. We have a general experience of 152 PM implantation in children. We analyzed 70 children with physiological PMs implanted since 1994. The average age on the moment of PM implantation is 9,6.+3,8 years (from 2 years 2 months till 15 years 9 months). Average follow-up period is 50,2.+28,7 months (1-70 months). All the children were divided into 3 groups depending of aetiology: 1 -congenital conducting system defects (N=23), 2 -myocarditis in history (N=15), 3 -surgically corrected congenital heart defects (N=14). Results: the significant difference between 1 and 2 groups is revealed on chronic atrial (2,5.+1,9 V vs 1,7_+0,7 V) and ventdcular (1,7+0,7 V vs 1,3_+0,4 V) pacing thresholds; between 2 and 3 groups -on atrial pacing thresholds (1,7.+0,7 V vs 2,7.+1,4 V); between 1 and 3 groups -on ventricular pacing thresholds (1,7.+0,7 V vs 1,1.+0,4 V). Conclusion: Thus, in children with congenital conductivity disturbances with absence of any heart pathology higher atrial and ventricular pacing thresholds were observed in comparison with children having postmyocarditis cardiosc...
Aim: The aim of the study was evaluation of the efficacy of prophylactic use of a single dose of a beta-lactamase antibiotic and aminoglycosideadministered locally and/or systemically during cardiac pacemaker insertion procedures. Materials and methods: The analysis was carried out over a period from 30.04.1992 to 30.06.2000. A total of 2215 procedures were carried out on 1072 women and 1143 men aged between 18 and 101 years (mean age 72,5 years). The following pacemakers were implanted: AAI/AAIR-122. WINVIR-1440, VDDNDDR-50, DDD/DDDR-293, BiA-4, BW-2, pacemakers were replaced in 264 patients (pts). Each procedure was preceded by intravenous administration of an antibiotic: beta-lactamasecephalospodn and aminoglycoside. Closure of the cavity was preceded by locally "washing it out" with the cephalosporin previously administered intravenously. Further administration of the antibiotic depended on the presence of risk of infection factors. These were assumed to be: temporary transvenous cardiac pacing, extended duration of procedure (50-60 min.), immunological disorders, diabetes, infectious foci not eliminated prior to the operation. The "standard" procedure -a single dose of antibiotic prior to the surgical procedure and topical administration -was performed in 1649 pts (74%). This method made it possible to avoid complications in the form of infection, during the 9-year observation pedod of the group of pts without risk factors, in 100% of cases. In 6 out of 566 pts (1,1%) with at least one risk of infection factor, inflammation developed above the course of the electrode. In all pts this complication was controlled by conservative therapy without necessitating removal of the system. Conclusions: The prophylactic antibiotic therapy scheme (single intravenous dose combined with local lavage of the pacemaker cavity) used in permanent cardiac pacing procedures enabled elimination of infectious complications in the group of pts without risk factors. We have a general experience of 152 PM implantation in children. We analyzed 70 children with physiological PMs implanted since 1994. The average age on the moment of PM implantation is 9,6.+3,8 years (from 2 years 2 months till 15 years 9 months). Average follow-up period is 50,2.+28,7 months (1-70 months). All the children were divided into 3 groups depending of aetiology: 1 -congenital conducting system defects (N=23), 2 -myocarditis in history (N=15), 3 -surgically corrected congenital heart defects (N=14). Results: the significant difference between 1 and 2 groups is revealed on chronic atrial (2,5.+1,9 V vs 1,7_+0,7 V) and ventdcular (1,7+0,7 V vs 1,3_+0,4 V) pacing thresholds; between 2 and 3 groups -on atrial pacing thresholds (1,7.+0,7 V vs 2,7.+1,4 V); between 1 and 3 groups -on ventricular pacing thresholds (1,7.+0,7 V vs 1,1.+0,4 V). Conclusion: Thus, in children with congenital conductivity disturbances with absence of any heart pathology higher atrial and ventricular pacing thresholds were observed in comparison with children having postmyocarditis cardiosc...
Do anesthetic agents change diagnostic value of transesophagealelectrophysiological study? SV Goureev VI Gordeev. DF Egorov. OL Gordeyev. AV Adrianov. VK Lebedeva Saint Petersburg. Russia
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.